Evidence map›Paper›PMID 40823577›Full record

ArticleFrontiers in medicine2025

Acute lymphoblastic leukemia with

Bo Liang, Tu Ni, Wenbin Ni, Xu Zhang, Qinqin Ai

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bo LiangDepartment of Hematology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Tu NiDepartment of Ultrasonography, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Wenbin NiDepartment of Radiology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Xu ZhangDepartment of Ultrasonography, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Qinqin AiDepartment of Hepatology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case presentation: A 27-year-old male ALL patient developed cutaneous infections on the right calf, left upper arm, and buttock during chemotherapy. Initial lesions presented as a 1.0 × 1.0 cm dark purple nodule on the right calf, progressing rapidly to black eschar, ulceration, and multiple metastatic lesions. Conclusion: Unusual skin lesions in immunocompromised patients, especially those with hematological malignancies receiving chemotherapy, warrant high suspicion for

Indexed as

acute lymphoblastic leukemiacutaneous infectionFusarium solaniimmunocompromisewound debridement

Identifiers

PMID40823577
PMCPMC12354598

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.